A share price of Neogenomics Inc [NEO] is currently trading at $10.1, up 3.27%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NEO shares have gain 1.81% over the last week, with a monthly amount glided 10.99%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Neogenomics Inc [NASDAQ: NEO] stock has seen the most recent analyst activity on July 30, 2025, when BTIG Research downgraded its rating to a Neutral. Previously, William Blair downgraded its rating to Mkt Perform on July 29, 2025. On May 15, 2025, Guggenheim initiated with a Neutral rating. Leerink Partners downgraded its rating to a Market Perform but stick to its price target of $9 on April 30, 2025. The Benchmark Company downgraded its rating to a Hold. Jefferies started tracking with a Buy rating for this stock on December 10, 2024, and assigned it a price target of $22.
Neogenomics Inc experienced fluctuations in its stock price throughout the past year between $4.72 and $19.11. Currently, Wall Street analysts expect the stock to reach $10.4 within the next 12 months. Neogenomics Inc [NASDAQ: NEO] shares were valued at $10.1 at the most recent close of the market. An investor can expect a potential return of 2.97% based on the average NEO price forecast.
Analyzing the NEO fundamentals
Trailing Twelve Months sales for Neogenomics Inc [NASDAQ:NEO] were 709.16M which represents 11.90% growth. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at -0.17%, Pretax Profit Margin comes in at -0.16%, and Net Profit Margin reading is -0.16%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.13 and Total Capital is -0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.49.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.71 points at the first support level, and at 9.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.38, and for the 2nd resistance point, it is at 10.66.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Neogenomics Inc [NASDAQ:NEO] is 3.91. Also, the Quick Ratio is 3.62, while the Cash Ratio stands at 1.68. Considering the valuation of this stock, the price to sales ratio is 1.84, the price to book ratio is 1.55.
Transactions by insiders
Recent insider trading involved ALICIA OLIVO, Officer, that happened on Oct 16 ’25 when 4918.0 shares were purchased. Chief Financial Officer, Sherman Jeffrey Scott completed a deal on Aug 06 ’25 to buy 20000.0 shares. Meanwhile, Chief Executive Officer Zook Anthony P. bought 17900.0 shares on Aug 06 ’25.
